Engineered adenovirus serotypes for overcoming anti-vector immunity

Clinical trial design for adenoviral gene therapy products

(2009) T. Shirakawa   DRUG NEWS & PERSPECTIVES

A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines

(2009) Daniela Peruzzi et al.   VACCINE

Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model

(2009) Anurag Sharma et al.   VIROLOGY

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults

(2008) Frances H. Priddy et al.   CLINICAL INFECTIOUS DISEASES

Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo

(2008) Ravi Singh et al.   FASEB JOURNAL

Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies

(2008) M Särkioja et al.   GENE THERAPY

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

(2008) Rafick-Pierre Sekaly   JOURNAL OF EXPERIMENTAL MEDICINE

DNA gag/Adenovirus Type 5 (Ad5) gag and Ad5 gag/Ad5 gag Vaccines Induce Distinct T-Cell Response Profiles

(2008) K. S. Cox et al.   JOURNAL OF VIROLOGY

Innate immune response induced by gene delivery vectors

(2007) Haruna Sakurai et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Adenovirus vector induced innate immune responses: Impact upon efficacy and toxicity in gene therapy and vaccine applications

(2007) Zachary C. Hartman et al.   VIRUS RESEARCH